$48.57
+0.08(0.17%)
Mkt Cap $20.8B
$30.85
$48.57
52-Week Range
At A Glance
1
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.
2
Revenue is primarily driven by Financial Royalty Assets (94.5%) and Royalty Income Other (5.5%).
3
Most recently: of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the (2026-02-11).
$20.8B
Market Cap
$2.4B
Revenue
$765M
Net Income
Employees75
Fundamentals
How The Business Makes Money
Revenue by Segment
Financial Royalty Assets94.5%($6.6B)
Royalty Income Other5.5%($388M)
Activity
Analyst View
Company Profile
CIK0001802768
ISINGB00BMVP7Y09
CUSIPG7709Q104
Phone212 883 0200
Address110 East 59th Street, New York City, NY, 10022, US
SEC EDGAR